Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on August 12, 2010. The filing serves to announce the company's financial and operational results for the quarter ended June 30, 2010. The detailed results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference but not deemed "filed" under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended June 30, 2010.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, specific risk factors, or discussion of unusual items. It strictly functions as a notification of the press release issuance.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated August 12, 2010) to obtain actual financial figures for the quarter ended June 30, 2010.
- Confirm the company's principal executive office address: One Park Place, Suite 450, Annapolis, Maryland 21401.
- Note that the information in this 8-K is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.